Top

Published in:

01-07-2020 | Coronavirus

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report

Authors: Bo Zhou, Jianqing She, Yadan Wang, Xiancang Ma

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2020

Abstract

The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for thrombosis. We report a case of very severe COVID-19 complicated with venous thrombosis and arteriosclerosis obliterans of lower extremities. Risk stratification for deep vein thrombosis and peripheral arterial disease are of vital importance for the prognosis of COVID-19.

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192CrossRef

Thompson RN (2020) Novel coronavirus outbreak in Wuhan, China, 2020: intense surveillance is vital for preventing sustained transmission in new locations. J Clin Med 9(2):498CrossRef

Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA (2019) Risk for transportation of, 2019 novel coronavirus disease from Wuhan to other cities in China. Emerg Infect Dis 2020. https://doi.org/10.3201/eid2605.200146 CrossRefPubMedPubMedCentral

Backer JA, Klinkenberg D, Wallinga J (2020) Incubation period of 2019 Novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill 25(5):2000062CrossRef

Liao X, Wang B, Kang Y (2020) Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units-the experience in Sichuan Province China. Intensive Care Med 46:357–360CrossRef

Eurosurveillance Editorial Team (2020) Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill 2020, 25(5) 2001231CrossRef

National Health Commission of China. New coronavirus pneumonia prevention and control program, 4th edn. http://www.gov.cn/zhengce/zhengceku/2020-01/28/5472673/files/0f96c10cc09d4d36a6f9a9f0b42d972b.pdf. Accesed 22 Jan 2020 (in Chinese)

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brunink S, Schneider J, Schmidt ML et al (2020) Detection of 2019 Novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25(3):2000045CrossRef

10.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513CrossRef

11.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al (2019) Clinical characteristics of 138 hospitalized patients with, Novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585 CrossRefPubMedPubMedCentral

12.

Wells PS, Forgie MA, Rodger MA (2014) Treatment of venous thromboembolism. JAMA 311(7):717–728CrossRef

13.

Cabeca TK, Bellei N (2012) Human coronavirus NL-63 infection in a Brazilian patient suspected of H1N1 2009 influenza infection: description of a fatal case. J Clin Virol 53(1):82–84CrossRef

Title: Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
Authors: Bo Zhou
Jianqing She
Yadan Wang
Xiancang Ma
Publication date: 01-07-2020
Publisher: Springer US
Keywords: Coronavirus
Venous Thrombosis
Phlebothrombosis
Peripheral Arterial Disease
COVID-19
Arterial Occlusive Disease
Thrombosis
Peripheral Arterial Disease
Venous Thrombosis
Type 2 Diabetes
Published in: Journal of Thrombosis and Thrombolysis / Issue 1/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02084-w

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Role of thrombin generation assays in the diagnosis of acute myocarditis and non-ST myocardial infarction

Toward understanding the 2019 Coronavirus and its impact on the heart

Should we monitor the direct oral anticoagulants?

Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition

Thank you to reviewers

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism